The ATS is pleased to announce the launch of the 2021 Corporate Member Program earlier this week.

Now entering its eleventh year, the Corporate Member Program serves as a forum to facilitate transparent discussions between the ATS and our colleagues in industry about issues and trends that may impact medicine and the advancement of science and patient care.

Since its inception, the program has welcomed companies of all sizes to participate, providing year-long engagement and visibility benefits that are interspersed at four different levels of support. One of the benefits of Corporate Membership at the Supporter level or higher is the opportunity to share current clinical trials in active recruitment on the ATS Clinical Trials Resources page. Currently this page has 18 trials listed in asthma, bronchiectasis, COPD, IPF, ILD, influenza, lung infection, PAH, and sarcoidosis from our Corporate Member partners.

Comprised of representatives from participating Corporate Member companies, the ATS Corporate Advisory Board is at the core of the program. The Advisory Board meets once a year to foster collaborative discussions with ATS leadership and executive staff and our industry colleagues and lay the foundation for future successful industry partnerships. ATS Corporate Members include both pharmaceutical and medical device companies that work in a broad range of disease areas, spanning the entire pulmonary, critical care, and sleep sphere. Their unique expertise enriches our Advisory Board discussions and can lead to new collaborative initiatives where we work to advance patient care together. This year’s annual meeting is planned for mid-fall 2021.

The strength and value of the Corporate Member Program continues to grow as the program has almost tripled in size in the past decade. For the 2021 program, the ATS is pleased to welcome the following six new Corporate Member companies.

Interested in learning more about ATS Corporate Membership? Please contact us for more details and a list of benefits for 2021.

Meet Our New ATS 2021 Corporate Members: